AMGN
Amgen Inc. (AMGN)
Last Price$318.9(2.6%)
Market Cap$173.1B
LTM P/E
42.3x
EPS growth
69.2%
PEGY
0.6x
Peter Lynch Fair Value
$542.3
Undervalued (Peter Lynch formula)
70.1%
Stock quality
6/10
Good

AMGN Peter Lynch Fair Value

Peter Lynch Fair Value Assumptions

as of Mar 12, 2025
LTM P/E
42.3x
EPS growth
69.2%
Dividend Yield
2.8%
PEGY
0.6x
Last share price
$318.9
Peter Lynch Fair Value
$542.3
70.1% undervalued

Peter Lynch Fair Value Calculation

PEGY
0.6x
=
LTM P/E
42.3x
/
(
EPS growth
69.17%
+
Dividend yield
2.79%
)
Peter Lynch
Fair Value
$542.3
=
Last share price
$318.9
/
PEGY
0.6x

Best stock ideas on the market right now

With Value Sense, you can find undervalued stocks list with intrinsic value. Discover more stock market investment ideas.

AMGN EPS growth & Dividend Yield

Annual
Quarterly
LTM
Industry Median
5Y Historical Average
Benchmark

AMGN vs Peer Set: Peter Lynch Fair Value Comparison

Explore more intrinsic value tools hub for AMGN

FAQ

What is Amgen Inc. fair value by Peter Lynch formula?

As of Mar 11, 2025, Amgen Inc.'s fair value using the Peter Lynch formula is $542.3 per share. The current price of $318.9 suggests Amgen Inc. may be undervalued by this metric.

What is Amgen Inc. Price to Earnings (P/E) ratio?

As of Mar 11, 2025, Amgen Inc.'s P/E ratio is 42.3x. This is calculated by dividing the current share price of $318.9 by the Earnings per Share (EPS) for the trailing twelve months, which is $7.6. The P/E ratio indicates how much investors are willing to pay for each dollar of earnings.

What is Amgen Inc. earnings per share (EPS)?

Amgen Inc. earnings per share (EPS) for the twelve months ending Mar 11, 2025, was $7.6, a 69.2% growth year-over-year.